Dosimetric and radiobiological benefits of patient-specific respiratory motion management for liver tumor stereotactic body radiotherapy

针对肝肿瘤立体定向放射治疗的患者特异性呼吸运动管理在剂量学和放射生物学方面的益处

阅读:2

Abstract

Respiratory motion management was crucial importance in radiotherapy. Our study aimed to explore the dosimetric and radiobiological benefits of various respiratory motion management strategies in liver tumor patients undergoing stereotactic body radiotherapy (SBRT). Respiratory motion images of 23 liver tumor patients were obtained by 4DCT scan under abdominal compression (AC) and free-breathing (FB). Group A included all 23 patients, while group B focused on 11 patients with tumors < 5 cm in diameter. Dosimetric and radiobiological parameters were recorded and compared across three treatment plans for each patient: Plan(FB), Plan(AC), and Plan(GAT(Respiratory gating)). For dosimetric parameters, compared to Plan(AC), Plan(GAT) further significantly reduced liver D(mean), V(d<21.5 Gy), V(10Gy); right kidney D(mean); duodenum D(mean), D(0.5cc), (1cc), (5cc), (10cc); intestine D(mean), D(0.5cc), (5cc), (10cc); stomach D(mean) and spinal cord D(mean), V(5Gy) in group A; however, in Group B, Plan(GAT) only showed significantly reductions in liver D(mean) and duodenum D(mean), D(5cc), (10cc). In terms of radiobiology, compared with Plan(FB), Plan(AC) significantly reduced liver NTCP (p = 0.033) in Group B, whereas no difference was observed in Group A (p = 0.231). Additionally, compared to Plan(AC), Plan(GAT) further reduced liver NTCP (p = 0.001), liver EUD (p < 0.001) and right kidney EUD (p < 0.001) in Group A; however, in Group B, Plan(GAT) did not significantly decrease liver NTCP (p = 0.136), indicating that AC offers comparable benefits to GAT. The Pearson's correlations between the reductions in dosimetric and radiobiological parameters and tumor motion or target volume were stronger in Group B than in Group A under AC. So, GAT provides the greatest dosimetric and radiobiological benefits for liver tumors treated with SBRT, while AC offers comparable benefits for liver tumors with < 5 cm in diameter. Thus, given its technical simplicity, AC is recommended for liver tumors < 5 cm in diameter undergoing SBRT.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。